 phase I/II study trichosanthin treatment HIV disease Trichosanthin ribosomal inhibitor protein blocks HIV replication lymphocytes macrophages agent patients advanced HIV disease dose-escalation study injections period dose range micrograms/kg injection maximum dose micrograms/kg Reversible severe fatigue myalgias major dose-limiting side-effects leucocytosis elevations serum transaminases reversible Non-dose-related reversible mental status changes patients drug dementia patients reversed sequelae death patient serum antigen levels month first infusion patients study elevated levels negative Values low end study period months patients cell levels cells/l significant decreases sedimentation rate cell numbers changes dose levels patients infusions